ACTA1 and breast carcinoma: αSMA expression has been intensely studied in breast cancer stromal-associated fibroblasts (CAFs) [10, 11], and it was proven that αSMA-positive CAFs increase breast cancer tumor stroma and influence tumor progression, metastatic potential, prognosis, and patients' overall survival [12-14].